DK0759773T3 - Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv - Google Patents

Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv

Info

Publication number
DK0759773T3
DK0759773T3 DK95921294T DK95921294T DK0759773T3 DK 0759773 T3 DK0759773 T3 DK 0759773T3 DK 95921294 T DK95921294 T DK 95921294T DK 95921294 T DK95921294 T DK 95921294T DK 0759773 T3 DK0759773 T3 DK 0759773T3
Authority
DK
Denmark
Prior art keywords
tear
topical application
ocular tissue
specific emulsions
fatty acid
Prior art date
Application number
DK95921294T
Other languages
Danish (da)
English (en)
Inventor
Walter L Tien
Orest Olejnik
Shulin Ding
Original Assignee
Allergan Sales Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0759773(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Sales Inc filed Critical Allergan Sales Inc
Application granted granted Critical
Publication of DK0759773T3 publication Critical patent/DK0759773T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95921294T 1994-05-17 1995-05-17 Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv DK0759773T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/243,279 US5474979A (en) 1994-05-17 1994-05-17 Nonirritating emulsions for sensitive tissue
PCT/US1995/006302 WO1995031211A1 (en) 1994-05-17 1995-05-17 Lacrimal gland specific emulsions for topical application to ocular tissue

Publications (1)

Publication Number Publication Date
DK0759773T3 true DK0759773T3 (da) 2001-11-26

Family

ID=22918100

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95921294T DK0759773T3 (da) 1994-05-17 1995-05-17 Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv
DK00202069T DK1044678T3 (da) 1994-05-17 1995-05-17 Tårekirtelspecifikke emulsioner til topisk anvendelse til okulært væv

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00202069T DK1044678T3 (da) 1994-05-17 1995-05-17 Tårekirtelspecifikke emulsioner til topisk anvendelse til okulært væv

Country Status (17)

Country Link
US (1) US5474979A (ja)
EP (2) EP1044678B1 (ja)
JP (2) JP3441462B2 (ja)
KR (2) KR100368181B1 (ja)
CN (2) CN1229136C (ja)
AT (2) ATE234076T1 (ja)
AU (1) AU693213B2 (ja)
BR (1) BR9507664A (ja)
CA (1) CA2190485C (ja)
DE (2) DE69529932T2 (ja)
DK (2) DK0759773T3 (ja)
ES (2) ES2194670T3 (ja)
GR (1) GR3036945T3 (ja)
HK (1) HK1034190A1 (ja)
NZ (1) NZ287635A (ja)
PT (2) PT1044678E (ja)
WO (1) WO1995031211A1 (ja)

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585104A (en) * 1995-04-12 1996-12-17 The Procter & Gamble Company Cleansing emulsions
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
JPH10218760A (ja) * 1997-02-04 1998-08-18 Nobel Igaku Kenkyusho:Kk ドライアイ治療用の微量油添加目薬
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
AUPQ228199A0 (en) * 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
ES2309410T5 (es) * 1999-10-15 2015-03-17 Sucampo Ag Nueva composición que contiene un compuesto bi-ciclico y un glicérido
US7270767B1 (en) 1999-10-18 2007-09-18 Foster-Miller, Inc. Environmentally friendly de-icer and anti-icer compositions
TR200302105T4 (tr) * 2000-04-07 2004-02-23 Laboratoire Medidom S. A. Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
CA2416169C (en) 2000-07-14 2008-09-23 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
EP1392355B1 (en) 2001-05-21 2007-02-14 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
JP2004527578A (ja) 2001-05-21 2004-09-09 アルコン，インコーポレイテッド ドライアイ障害を処置するためのＮＦ−κＢインヒビターの使用
US7112588B2 (en) 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
CA2461730C (en) * 2001-10-19 2012-05-15 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
US6656460B2 (en) 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US6984628B2 (en) 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
WO2006007510A1 (en) 2004-07-01 2006-01-19 Schepens Eye Research Compositions and methods for treating eye disorders and conditions
US20080188560A1 (en) * 2004-07-01 2008-08-07 Fatemeh Mohammadi Cosmetic Compositions and Methods For Sensory Cooling
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
CN100478025C (zh) * 2005-03-25 2009-04-15 中国科学院上海药物研究所 一种环孢菌素a眼用微乳制剂及其制备方法
CN100562340C (zh) * 2005-06-17 2009-11-25 中国科学院上海药物研究所 一种微乳型人工泪液
CN1319515C (zh) * 2005-07-12 2007-06-06 沈阳何氏生物工程有限公司 活肤眼霜
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
CA2628570A1 (en) * 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US11311477B2 (en) 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
WO2008137617A1 (en) * 2007-05-04 2008-11-13 Allergan, Inc. Use of cyclosporines in the treatment of patients with intraocular lenses
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
JP5668476B2 (ja) 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
KR100985279B1 (ko) * 2008-03-05 2010-11-05 디렉스 팜 (주) 안구건조증 치료를 위한 안약조성물 및 그 제조방법
AU2009268549B2 (en) * 2008-07-10 2015-07-16 Allergan, Inc. Cyclosporin derivatives for treating ocular and dermal diseases and conditions
US20100016219A1 (en) * 2008-07-19 2010-01-21 Jerry Zhang Ophthalmic compositions containing solubilized cyclosporin
FR2938757B1 (fr) * 2008-11-27 2010-12-31 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
AU2010203609A1 (en) 2009-01-08 2011-07-21 Allergan, Inc. Compositions for enhancing nail growth
US20110009339A1 (en) 2009-04-14 2011-01-13 Allergan, Inc Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
US20100279951A1 (en) * 2009-05-01 2010-11-04 Aileen Morgan Method of treating allergic conjunctivitis with cyclosporin compositions
MX2011013007A (es) 2009-06-05 2012-02-28 Allergan Inc Lagrimas artificiales y usos terapeuticos.
WO2010144194A1 (en) 2009-06-09 2010-12-16 Lux Biosciences, Inc. Topical drug delivery systems for ophthalmic use
HUE040019T2 (hu) 2009-11-09 2019-02-28 Allergan Inc Hajnövekedést stimuláló készítmények és módszerek
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
CN101897949B (zh) * 2010-02-24 2016-07-06 温士顿医药股份有限公司 低刺激性透明乳化液剂型以供眼睛或眼睛周围有关组织表面免疫调节及消炎的眼用药物组合物
WO2011150102A1 (en) * 2010-05-25 2011-12-01 Allergan, Inc. Cyclosporin emulsions
WO2012015211A2 (ko) * 2010-07-30 2012-02-02 주식회사종근당 사이클로스포린 에이 함유 점안제 조성물
US8501796B2 (en) 2010-09-16 2013-08-06 Allergan, Inc. Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
JP5805773B2 (ja) 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンアナログ
BR112013008864A2 (pt) 2010-10-12 2016-06-28 Allergan Inc análogos d ciclosporina
JP6042343B2 (ja) 2010-11-18 2016-12-14 スティーヴン ヨーリン 毛髪成長のための組成物及び方法
WO2013172838A1 (en) 2012-05-17 2013-11-21 Steven Yoelin Compositions and methods for hair growth
US9018202B2 (en) 2010-12-03 2015-04-28 Allergan, Inc. Methods for treating diseases of the retina
WO2012091278A2 (ko) * 2010-12-28 2012-07-05 한림제약(주) 나노에멀젼 형태의 안과용 조성물
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
RU2599036C2 (ru) 2011-01-26 2016-10-10 Аллерган, Инк. Андрогенная композиция для лечения офтальмологического заболевания
JP6105494B2 (ja) * 2011-03-14 2017-03-29 ドラッグ デリバリー ソリューションズ リミテッド 眼科用組成物
JP6163482B2 (ja) 2011-05-27 2017-07-12 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンａの結晶形態、その調製方法、およびその使用のための方法
BR112013034051A2 (pt) * 2011-06-29 2019-09-24 Allergan Inc formulações de macrogol 15 hidroxiestearato
US20130029919A1 (en) 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery
DE102011108948A1 (de) 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
KR20140097152A (ko) * 2011-10-05 2014-08-06 알러간, 인코포레이티드 손발톱 건강을 증진하기 위한 조성물
WO2013052424A2 (en) 2011-10-05 2013-04-11 Allergan, Inc. Compositions for enhancing nail health
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
RU2641963C2 (ru) 2011-11-15 2018-01-23 Аллерган, Инк. Взвеси циклоспорина а формы 2
CA2856074C (en) 2011-11-15 2017-07-04 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
US9095576B2 (en) 2011-11-21 2015-08-04 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US20130197002A1 (en) 2012-01-30 2013-08-01 Allergan, Inc. Brimonidine for treating visual disorders mediated by central visual projections from the eye
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
CA2874548A1 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
US9402913B2 (en) 2013-03-08 2016-08-02 Allergan, Inc. Cyclosporine A steroid conjugates
KR101492447B1 (ko) 2013-05-20 2015-02-23 주식회사태준제약 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법
WO2016011449A1 (en) * 2014-07-18 2016-01-21 Allergan, Inc. Suspension compositions of cyclosporin a for subconjunctival and periocular injection
WO2016085885A1 (en) 2014-11-25 2016-06-02 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
ES2922815T3 (es) 2015-02-06 2022-09-20 Woodstock Sterile Solutions Inc Preparación de una emulsión de aceite en agua para formulaciones farmacéuticas estabilizadas con polímeros
EP3277704A1 (en) 2015-03-31 2018-02-07 Allergan, Inc. Cyclosporins modified on the mebmt sidechain by heterocyclic rings
KR101587385B1 (ko) 2015-07-29 2016-01-21 국제약품공업주식회사 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
FR3041883B1 (fr) * 2015-10-02 2019-03-15 Chu Clermont-Ferrand Procede de preparation d'un collyre de ciclosporine a
US10286035B2 (en) 2015-10-14 2019-05-14 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
CN106692052B (zh) * 2015-11-13 2021-03-26 天津金耀集团有限公司 一种环孢素眼用乳剂组合物
CN109963556A (zh) * 2016-11-17 2019-07-02 千寿制药株式会社 乳剂滴眼液
KR102115158B1 (ko) 2016-11-29 2020-05-26 주식회사 지트리파마슈티컬 티모신 베타 4 를 함유하는 제형
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
USD841152S1 (en) 2017-06-27 2019-02-19 Monica S. Naylor Eye drop container
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
CN109010268B (zh) * 2018-09-28 2020-07-10 湖北远大天天明制药有限公司 一种提高氯霉素稳定性的眼用组合物及其制备方法
WO2020250252A1 (en) 2019-06-11 2020-12-17 Sifi S.P.A. Microemulsion compositions
EP3996671A1 (en) * 2019-07-12 2022-05-18 Pharmathen S.A. Preservative free pharmaceutical composition for ophthalmic administration containing cyclosporine
BR112022000229A2 (pt) 2019-08-07 2022-02-22 Aneira Pharma Inc Composição para uso no tratamento da perda de cabelo
GR1010012B (el) * 2020-05-12 2021-05-27 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη
CN113749092B (zh) * 2020-06-03 2024-10-11 迈克斯(如东)化工有限公司 不饱和脂肪酸酯化物应用、农化组合物和低眼刺农药制剂及其应用
IL294896A (en) * 2022-07-20 2024-02-01 LYOTROPIC DELIVERY SYSTEMS Ltd Topical administration of cyclosporine to the eye
WO2024150216A1 (en) * 2023-01-09 2024-07-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Topical compositions and methods for treating alopecia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH204625A (de) * 1937-07-13 1939-05-15 Telefunken Gmbh Eisenkernspule mit als Drehkondensator ausgebildetem Abgleichkondensator.
US2224205A (en) * 1938-07-18 1940-12-10 Hoover Co Suction cleaner
ATE6466T1 (de) * 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
JPS59196816A (ja) * 1983-04-22 1984-11-08 Senjiyu Seiyaku Kk 水溶性アズレン誘導体の安定な水溶液の製造法
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
KR920003601B1 (ko) * 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
EP0327280B1 (en) * 1988-01-29 1992-03-18 Sankyo Company Limited Cyclosporin compositions
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CA2052950A1 (en) * 1990-10-10 1992-04-11 David P. Evitts Aqueous ophthalmic microemulsions of tepoxalin
JPH0558906A (ja) * 1991-09-06 1993-03-09 Sankyo Co Ltd シクロスポリン点眼製剤
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法

Also Published As

Publication number Publication date
GR3036945T3 (en) 2002-01-31
AU693213B2 (en) 1998-06-25
EP1044678B1 (en) 2003-03-12
DK1044678T3 (da) 2003-07-14
JPH10500414A (ja) 1998-01-13
DE69529932D1 (de) 2003-04-17
US5474979A (en) 1995-12-12
CN1288722A (zh) 2001-03-28
JP2003231646A (ja) 2003-08-19
JP4119284B2 (ja) 2008-07-16
CA2190485C (en) 2003-04-15
CN1152876A (zh) 1997-06-25
EP1044678A1 (en) 2000-10-18
PT759773E (pt) 2002-02-28
CA2190485A1 (en) 1995-11-23
WO1995031211A1 (en) 1995-11-23
KR100450703B1 (ko) 2004-10-01
CN1198587C (zh) 2005-04-27
PT1044678E (pt) 2003-08-29
BR9507664A (pt) 1997-10-07
CN1229136C (zh) 2005-11-30
MX9605599A (es) 1998-08-30
ES2194670T3 (es) 2003-12-01
ATE203911T1 (de) 2001-08-15
AU2640995A (en) 1995-12-05
JP3441462B2 (ja) 2003-09-02
HK1034190A1 (en) 2001-10-19
DE69522104D1 (de) 2001-09-13
DE69529932T2 (de) 2003-12-18
KR100368181B1 (ko) 2003-04-10
EP0759773A1 (en) 1997-03-05
EP0759773B1 (en) 2001-08-08
ATE234076T1 (de) 2003-03-15
ES2161895T3 (es) 2001-12-16
NZ287635A (en) 1998-09-24
DE69522104T2 (de) 2002-04-25

Similar Documents

Publication Publication Date Title
DK1044678T3 (da) Tårekirtelspecifikke emulsioner til topisk anvendelse til okulært væv
DE50013111D1 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
ATE141780T1 (de) Öl in wasser emulsionen verwendbar für die herstellung von einer creme
ATE326941T1 (de) Kosmetische und dermatologische zubereitungen auf der grundlage von o/w-emulsionen
ATE283031T1 (de) Nichtirritierende kosmetische und pharmazeutische zusammensetzungen
FR2702391B1 (fr) Nouvelles émulsions multiples, leur préparation, leur application à la préparation de compositions cosmétiques et ces compositions cosmétiques.
DE69727849D1 (de) Cyclosporin-Emulsionen
DE69310477D1 (de) Wasser-in-öl Emulsionen mit einer Fluorkohlenwasserstoff enthaltenden kontinuierlichen Phase und die Verwendung von gewissen Silikon Tenziden für ihre Herstellung
EP1072247A3 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
EP0832643A3 (en) Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
ATE303126T1 (de) Mindestens ein unlösliches organisches uv-filter enthaltende emulsionen ohne emulgatoren
DE60000223D1 (de) O/W-Emulsion enthaltende Fibern und ihre Verwendung in der Kosmetik
ATE210953T1 (de) Kosmetische pit-emulsionen
FR2720228B1 (fr) Nouvelles compositions pesticides du type "émulsion huile dans l'eau".
TR200102995T2 (tr) PIT-emülsiyonların fermantasyon işlemlerinde kullanımı
DE69418892D1 (de) Selbstemulgierende formulierung zur bildung einer öl-in-wasser-emulsion
CA2309033A1 (en) Lacrimal gland specific emulsions for topical application to ocular tissue